Launched by the National Cancer Institute in 2021, Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT) aims to develop a network for collaborative research in precision cancer prevention and interception.
More info: t.ly/wlcI_ or ncicapit.org.
Some highlights from the just-concluded #CAPITSummit 🎉
www.linkedin.com/posts/nci-ca...
Back from the @ncicapit.org Summit! Honored to contribute to designing vaccines for cancer before it emerges. Advocates J. Ahlstrom @healthtreeorg.bsky.social, E. Krischner (Li-Fraumeni), & R. Dubin @aliveandkickn.bsky.social reminded us why this research matters #CancerPrevention #Lynchsyndrome
Postdoctoral Associate Position-Project Description
Postdoc Opportunity in Neoepitope-based Cancer Immune Interception! Join our @ncicapit.org research at @weillcornell.bsky.social to link immunoprevention targets with preclinical cancer preventive interventions. Apply by emailing blanderadmin@med.cornell.edu. #Postdoc #immunology #cancervaccines
Final call to register for the March 30 CAP-IT Summit!
forms.gle/19GKAY6ADTXs...
Don’t miss the opportunity to engage with leaders in cancer prevention and interception.
📣Faculty recruitment - cancer interception researcher
at Fox Chase Cancer Center. See JD 👇
Only a few spots remaining! This is a great opportunity for early stage investigators to showcase their work to a broad scientific community.
prevention.cancer.gov/funding-and-...
At today’s Bioinformatics & Computational Biology #CAPITWGMeeting, WG Chair Dr. Alan Hutson of @roswellpark.bsky.social k provided working group updates, and Dr. Li Zhang of Fox Chase Cancer Center presented on “Bayesian Compositional Models for Analyzing Microbiome Data.”
Dr. Yongfeng He, CAP-IT nvestigator in Dr. Vivek Mittal Lab at Weill Cornell Medicine, will present their vaccine research at the Major Symposium 5 " New Breakthroughs in TCR Engineering" at the AACR Immuno-Oncology Conference in Los Angeles.
🗓 Feb 20 | 9:30–11:00 AM PT
www.aacr.org/meeting/aacr...
🧬 CIP-Net Project Spotlight
UG3CA290454 is developing a preventive cancer vaccine for people with inherited BRCA1/2 mutations, using chimeric RNA-derived neoantigens to stop breast cancer before it forms.
👉Learn more on the CIP-Net website: www.nci-cipnet.org/en/members/u...
Join us at the CAP-IT Summit on March 30, 2026! The event is open to the public.
ncicapit.org/en/cap-it-su...
Save the date! The #CAPITSummit is happening on March 30, 2026.
A full day of science, strategy, and community—bringing together researchers, clinicians, and advocates to advance cancer prevention and interception.
Register now and join us:
tinyurl.com/5c6snwyz
Save the date! The hashtag#CAPITSummit is happening on March 30, 2026.
A full day of science, strategy, and community - bringing together researchers, clinicians, and advocates to advance cancer prevention and interception.
Register now and join us:
tinyurl.com/5c6snwyz
At today’s #CAPIT Bioinformatics & Computational Biology WG meeting, Dr. Chi Zhang of University of Nebraska - Lincoln presented his work on AI-powered image feature extraction and data synthesis in pancreatic cancer.
The latest CAP-IT Newsletter is out!
It features highlights and reports from the July 2025 CAP-IT Summit, along with updates on network progress:
indd.adobe.com/view/32541c2...
New Tools and Resources from the NCI Data Sharing Hub , now added to the CAP-IT Shared Resources Catalog. Check it out and all NCI/NIH Shared resources at the link below:
ncicapit.org/en/resources...
The amazing @ptorresayuso.bsky.social from #FoxChaseCancerCenter and #TempleUniversity presenting his exciting research at the @ncicapit.bsky.social summit
The 2025 Annual @ncicapit.bsky.social Summit is #Outofthisworld good!!! The plenary speaker #EvaSzabo, the keynote presentation by #RafiAhmed followed by AI guru #ChanghueiYang & #force ‘s #SueFredman & panelist for #EmergingTechnologies lead by the amazing #ShannonHughes were extraordinary!!!
Don't wait - register now for the CAP-IT Virtual Annual Summit on July 24, 2025!
Open to the public with exciting talks on cancer prevention and interception.
🔗 Register: tinyurl.run/M3wsBV
ℹ️ Info: ncicapit.org
📧 CAP-IT@nih.gov
#CancerPrevention #NCICAPIT
A personalized neoantigen vaccine + Montanide/poly-ICLC/ipilimumab reshapes the T cell landscape in melanoma patients:
- Strong CD8+ responses
- TCR repertoires expanded beyond anti–PD-1
- Vaccine-specific TILs identified post-treatment
www.cell.com/cell/abstrac...?
#Neoantigen #Melanoma #Tcells
We have a great lineup of events this summer, we hope you can join us!
New in @cellcellpress.bsky.social : Exercise boosts immune checkpoint inhibitor (ICI) efficacy in #Melanoma via microbiota-derived formate, which enhances CD8⁺ T cell immunity through Nrf2 activation.
cell.com/cell/abstrac...
#Immunotherapy #Microbiome #CancerResearch
New in @thelancet.com : A comprehensive review on cancer vaccines and their role in shaping the future of immunotherapy.
Read here:
www.thelancet.com/journals/lan...
New @thelancet.com - Retifanlimab with carboplatin and paclitaxel for locally recurrent or metastatic squamous cell carcinoma of the anal canal (POD1UM-303/InterAACT-2): a global, phase 3 randomised controlled trial
www.thelancet.com/journals/lan...
#GastroSky #MedSky #OncSky
New study in Cell: HIF upregulates endogenous retroviruses in clear cell kidney cancer, generating tumor-specific antigens. ERV-targeting T cells show promise for immunotherapy and HIF stabilizers may unlock similar responses in other tumors. #CAPITPublication
pubmed.ncbi.nlm.nih.gov/40023154/
We’re excited to announce that the CAP-IT Virtual Annual Summit will be held on July 24, 2025!
Register here:
docs.google.com/forms/d/e/1F...
For more information, visit : ncicapit.org or email: CAP-IT@nih.gov #CancerPrevention #NCICAPIT
